The Cancer Letter

Inside information on cancer research and drug development

In Brief

Choi Named OncoDermatology Chief at Northwestern Memorial

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

JENNIFER NAM CHOI was named chief of the Division of OncoDermatology at Northwestern Memorial Hospital and associate professor in the Department of Dermatology at Northwestern University Feinberg School of Medicine. Choi will also join the melanoma team at Northwestern Medicine.

The Division of OncoDermatology is comprised of dermatologists who specialize in treating the mucocutaneous complications of cancer treatments and comprises one of five units within Northwestern Medicine’s Skin Cancer Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Specifically, Choi’s team provides care for skin, mucosal, hair and nail toxicities in patients undergoing cancer treatment, including chemotherapy and radiation. Her team also manages toxicities that may arise as a result of stem cell or solid organ transplantation—utilizing its graft-vs-host disease program, the skin cancer surveillance initiative for high-risk patients and Northwestern Memorial’s extracorporeal photopheresis unit.

Choi was the founder and director of the Yale Oncodermatology Clinic at Yale School of Medicine since 2008, and also served as the Melanoma Unit Disease Team co-leader at the Yale Cancer Center since 2009.

Table of Contents

YOU MAY BE INTERESTED IN

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
By Melinda Krigel
Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
By NRG Staff
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account